About Staff
Huang, Yu-Ying is currently serving as a section manager of Biomedical and Healthcare Policy Section. She specializes in legal and policy analysis in the fields such as health care, medical IT, and Software as a Medical Device (SaMD). Her main responsibilities include implementing biomedical legal projects in fields such as precision medicine, innovative biopharmaceuticals, and digital therapeutics, as well as promoting collaboration between industry, academia, and research institutions.
．National Sun Yat-Sen University, Department of Business Management, PH.D
．National Sun Yat-Sen University, Department of Business Management, Master Degree
．National Taiwan University, Department of Political Science, Bachelor's degree
．Science & Technology Law Institute, Institute for Information Industry / Principal Analyst (April 25, 2022-)
．Digital Development Office, Fwusow Industry Co., Ltd / Special Assistant (May 17, 2021 – April 22, 2022)
．Digital Transformation Institute, Institute for Information Industry / Principal Analyst (April 2, 2018 – May 31, 2021)
．Healthcare Services Department, Commerce Development Research Institute / Director (June 13, 2014 – March 31, 2018)
．Department of Quality Management, Taipei Medical University Shuang-Ho Hospital / Deputy director (November 1, 2011 – May 30, 2012)
．Management Department, Antai Tian-Sheng Memorial Hospital Director / Director (August 13, 2007 – October 31, 2010)
Thesis
．Huang, Yu-Ying, An empirical study of postponement application for large manufacturers in electronic/IT, clothing, and electric appliances industries (Jan 2008) (unpublished Ph.D. dissertation, National Sun Yat-Sen University).
．Huang, Yu-Ying, Postponement Strategies in Dynamic Environment─in terms of Standardization and Modularity (June 2002) (unpublished M.D. dissertation, National Sun Yat-Sen University).
Books
．Huang, Yu-Ying, Lin, Li-hui, Liu, Zhi-Sheng, & Lin Bo-Wen, RETIREMENT 3.0: ELDERLY EDUCATION AND HIGHER EDUCATION TRANSFORMATION (1st ed. 2019).
Article
．Yu-Ying Huang, U.S. Food and Drug Administration Updates the Draft Guidance for the Breakthrough Devices Program Guidance, SCIENCE AND TECHNOLOGY LAW REVIEW, 35(1), 7-9 (2023).
．Yu-Ting Cheng & Yu-Ying Huang, Draft overview for the reform of the EU pharmaceutical legislation, ITIS (July 28, 2023).
．Yu-Ying Huang, Analyzing the Policy and Impacts related to Prescription Drug Pricing Controls and Medicare Reform in the U.S. Inflation Reduction Act, SCIENCE AND TECHNOLOGY LAW REVIEW, 35(11), 20-47 (2023).
．Yu-Ying Huang, U.S. Drug Enforcement Administration announces two proposed rules on telemedicine prescribing of controlled substances, SCIENCE AND TECHNOLOGY LAW REVIEW, 35(12), 19-26 (2023).
．ISO/IEC 27001:2022 Lead Auditor (Information Security Management Systems)
．ISO/IEC 27701:2019 Lead Auditor (Privacy Information Management System)